{{Rsnum
|rsid=2069521
|Chromosome=15
|position=74746626
|Orientation=plus
|GMAF=0.05969
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.5 | 0.0 | 98.5
| HCB | 0.0 | 18.2 | 81.8
| JPT | 0.0 | 6.7 | 93.3
| YRI | 0.0 | 20.6 | 79.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 18.2 | 81.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2069521
|Name_s=CYP1A2:(-)3113A>G
|Gene_s=CYP1A2
|Feature=
|Evidence=PubMed ID:16153396
|Annotation=Associated with decreased activity.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161145045
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2069521
|overall_frequency_n=7
|overall_frequency_d=128
|overall_frequency=0.0546875
|n_genomes=5
|n_genomes_annotated=0
|n_haplomes=5
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=2
|webscore=N
|n_web_uneval=10
}}
{{PMID Auto
|PMID=22722500
|Title=Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response.
}}

{{on chip | 23andMe v3}}